{"text": "antipsychotics, leading to changes in drug efficacy. For instance, a study on\n\nolanzapine found that obese patients had higher plasma concentrations\n\ncompared to non-obese patients (Kaplan et al., 2017). This may be attributed\n\nto the increased volume of distribution in obese individuals.\n\nMechanisms Underlying Weight-Related Changes\n\nSeveral mechanisms have been proposed to explain the weight-related\n\nchanges in antipsychotic pharmacodynamics. These include:\n\n   \u2022 Increased body fat leading to higher drug concentrations", "embedding": []}